Status:
RECRUITING
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
Lead Sponsor:
Gene Solutions
Collaborating Sponsors:
The Medical Genetics Institute (MGI) of HCMC
Conditions:
Metastatic Cancers
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to investigate the real-world treatment landscape of patients with metastatic cancer and determine the role of ctDNA in monitoring treatment response in patient...
Detailed Description
Study design: This is a prospective, longitudinal, non-interventional study. Samples will be collected from patients with metastatic cancer who have undergone K4Care testing at Gene Solutions from 03/...
Eligibility Criteria
Inclusion
- Pathological and imaging confirmation of metastatic or progressive stage IV cancer.
- Consent to the use of their clinical data.
- Diagnosis of one of the following common solid tumor types: lung, colorectal, breast, gastric, or cancer of unknown primary origin.
- Prior K4Care testing to identify tumor tissue (FFPE) mutations and consent to the use of their sequencing data.
Exclusion
- Refusal to participate in the study.
- Absence of prior K4Care testing.
- Diagnosis of early-stage cancer or hematologic malignancy.
- Refusal to provide clinical information or blood samples.
Key Trial Info
Start Date :
April 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06929910
Start Date
April 9 2025
End Date
June 30 2027
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Genetics Institute
Ho Chi Minh City, Hồ Chí Minh, Vietnam